The European Heart Rhythm Association symptom classification for atrial fibrillation: Validation and improvement through a simple modification

Europace

Volumn 16, Issue 7, 2014, Pages 965-972

  Wynn, Gareth J ^a,b,c   Todd, Derick M ^a,b,c   Webber, Matthew ^a,b   Bonnett, Laura ^d   McShane, James ^b   Kirchhof, Paulus ^e,f   Gupta, Dhiraj ^a,b,c  

^a Institute of Cardiovascular Medicine (ICMS)   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Atrial fibrillation; EHRA; Quality of life; Symptom score; Symptoms

Indexed keywords

ADULT; ARTICLE; CLASSIFICATION; EUROPE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; VALIDATION STUDY; VISUAL ANALOG SCALE; AGED; ATRIAL FIBRILLATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DISCRIMINANT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH STATUS; HEALTH STATUS INDICATOR; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; UTILIZATION;

AGED; ATRIAL FIBRILLATION; COST-BENEFIT ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84904018856     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut395     Document Type: Article

References (29)

1. Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY et al. Prevalence of atrial fibrillation in the general population and in high-risk groups: The ECHOES study. Europace 2012;14:1553-9
2. Bonhorst D, Mendes M, Adragao P, De SJ, Primo J, Leiria E et al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: The FAMA study. Rev Port Cardiol 2010;29:331-50
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5
4. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: Cluster randomised controlled trial. BMJ 2007;335:383
5. Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL et al. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: A Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol 2006;48: 721-30
6. Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM et al. Validation of a newsimple scale tomeasure symptoms inatrialfibrillation: TheCanadianCardiovascular Society Severity in Atrial Fibrillation scale. Circ Arrhythm Electrophysiol 2009;2:218-24
7. Dorian P, JungW, NewmanD, Paquette M, Wood K, AyersGMet al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: Implications for the assessment of investigational therapy. J AmColl Cardiol 2000;36:1303-9
8. Hawe E, Baillie L, Praet C. Estimating the direct costs of atrial fibrillation to theNHSin the constituent countries of the UK and at SHA level in England, an OHE Consulting Report. London: The Office of Health Economics; 2009
9. Kirchhof P, AuricchioA, Bax J, CrijnsH, CammJ, DienerHCet al.Outcome parameters for trials in atrial fibrillation: Recommendations froma consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23
10. Ganiats TG, BrownerDK, Dittrich HC.Comparison of quality of well-being scale and NYHA functional status classification in patients with atrial fibrillation. New York Heart Association. Am Heart J 1998;135(Pt 1):819-24
11. Chiang CE, Naditch-Brule L, Murin J, Goethals M, Inoue H, O'Neill J et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: Insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 2012;5:632-9
12. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12:1360-420
13. CammAJ, LipGY, DeCR, Savelieva I, AtarD, Hohnloser SHet al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14: 1385-413
14. Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H et al. Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: Data from the RealiseAF cross-sectional international registry. Heart 2012; 98:195-201
15. Kirchhof P, Breithardt G, CammAJ, Crijns HJ, Kuck KH, Vardas P et al. Improvingoutcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Am Heart J 2013;166:442-8
16. Kirchhof P, Ammentorp B, Darius H, de Caterina R, Le Heuzey J, Schilling RJ et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC guidelines on atrial fibrillation: Primary results of the prevention of thromboembolic events - European Registry in Atrial Fibrillation Registry. Europace 2014;16:6-14
17. Spertus J, Dorian P, Bubien R, Lewis S, Godejohn D, ReynoldsMRet al.Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:15-25
18. The EuroQol Group: EuroQol - A new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208
19. Brooks R. EuroQol: The current state of play. Health Policy 1996;37:53-72
20. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005;14:1523-32
21. McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S et al. Costeffectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart 2009;95:542-9
22. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41
23. Jansson KA, Granath F. Health-related quality of life (EQ-5D) before and after orthopedic surgery. Acta Orthop 2011;82:82-9
24. Roalfe AK, Bryant TL, Davies MH, Hackett TG, Saba S, Fletcher K et al. A crosssectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: Secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study. Europace 2012;14:1420-7
25. Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P et al. ESC-EURObservational Research Programme: The Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Europace 2012;14: 1094-103
26. Rumsfeld JS, Alexander KP, Goff DC Jr, Graham MM, Ho PM, Masoudi FA et al. Cardiovascular health: The importance of measuring patient-reported health status: A scientific statement from the American Heart Association. Circulation 2013;127: 2233-49
27. Berg J, Lindgren P, NieuwlaatR, Bouin O, CrijnsH. Factorsdetermining utilitymeasured with the EQ-5D in patients with atrial fibrillation. Qual Life Res 2010;19:381-90
28. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, DaviesDWet al. Atrial fibrillation management: A prospective survey in ESC member countries: The Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-34
29. Frost MH, Bonomi AE, Ferrans CE, Wong GY, Hays RD. Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clin Proc 2002;77:488-94